Tweet Fingolimod was the first sphingosine-1-phosphate receptor modulator and in Europe is used second line after failure of a previous drug, siponimod is licenced in Europe for secondary progressive MS, ozanimod (not really used in UK) and ponseimod can be used first line for relapsing MS. They all target S1P1 receptor and in other countries…
New imaging tool detects damaged myelin across large brain areas
Researchers have developed a highly sensitive imaging technique that can detect damage to myelin, the fatty wrapping around nerve fibers that is damaged in multiple sclerosis (MS), in large areas […] The post New imaging tool detects damaged myelin across large brain areas appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
FDA approves use of robotic exoskeleton for MS rehabilitation
A robotic exoskeleton dubbed Atalante X, which allows people with severe mobility issues to stand upright for rehabilitation exercises, is now cleared by the U.S. Food and Drug Administration (FDA) for […] The post FDA approves use of robotic exoskeleton for MS rehabilitation appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
I’m learning what drains and recharges my MS social battery
I was probably never as outgoing or sociable as some people, but there was a time when I genuinely enjoyed most social activities. I was the guy who, by the […] The post I’m learning what drains and recharges my MS social battery appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Ashley’s Journey: Team MSAA and Ironman World Championship
In 2017, Ashley Norton received a diagnosis of multiple sclerosis and set a remarkable goal: to compete in the Ironman World Championship – all 140.4 miles of it. This dream of swimming 2.4 miles, biking 112 miles, and running 26.2 … Continue reading → Source: blog.mymsaa.org
Clean Your Teeth
Tweet Could ProfAngry hold the key to controlling MS. ProfA is a bit of a boffin and has more ideas thatn you can shake a stick at. Although you may know him for making tests for antibodies that we use in MS….ProfA is part of the Dentistry Faculty and researches dental problems too…He is looking…
Experimental MS therapy safely reaches brain in first human trial
SUDO-550, an oral TYK2 inhibitor being developed by Sudo Biosciences, was found to be safe, well-tolerated, and to fully reach the brain in a first-in-human clinical trial involving healthy volunteers, […] The post Experimental MS therapy safely reaches brain in first human trial appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
The end of daylight saving time gives me a chance to rest
On Sunday, Nov. 2, daylight saving time ended, our clocks “falling back” an hour. This time of year is difficult for many because the sun sets earlier and the evenings […] The post The end of daylight saving time gives me a chance to rest appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Midweek Inspiration
Happy midweek to y’all! I hope you have been having a good week and that you are feeling as well as you can. I set a goal to write one post a day, but unfortunately, I have not been able to. Life is an incredible thing we have been honored with, but many things can…
Trying Your Best to Catch Some ZZ’s
Sleep…. This word can generate a mixture of feelings for many. Some people find it so easy to just lay their head down, turn off the inside chatter of their mind for a bit, and fall into a good snooze. … Continue reading → Source: blog.mymsaa.org